Various studies have been conducted on the recurrence risk, duration of adjuvant chemotherapy, molecular subtypes, TN categorization, treatment and survival trends, and impact of age and comorbidity on adjuvant treatment outcomes for stage II and III colon cancer. Additionally, guidelines for endoscopic surveillance after surgical or endoscopic resection have been established by the European Society of Gastrointestinal Endoscopy and European Society of Digestive Oncology.